Inhibition of Plasmodium Liver Infection by Ivermectin
Avermectins are powerful endectocides with an established potential to reduce the incidence of vector-borne diseases. Here, we show that several avermectins inhibit the hepatic stage of Plasmodium infection in vitro Notably, ivermectin potently inhibits liver infection in vivo by impairing parasite...
Saved in:
Published in | Antimicrobial agents and chemotherapy Vol. 61; no. 2 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Society for Microbiology
01.02.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Avermectins are powerful endectocides with an established potential to reduce the incidence of vector-borne diseases. Here, we show that several avermectins inhibit the hepatic stage of Plasmodium infection in vitro Notably, ivermectin potently inhibits liver infection in vivo by impairing parasite development inside hepatocytes. This impairment has a clear impact on the ensuing blood stage parasitemia, reducing disease severity and enhancing host survival. Ivermectin has been proposed as a tool to control malaria transmission because of its effects on the mosquito vector. Our study extends the effect of ivermectin to the early stages of mammalian host infection and supports the inclusion of this multipurpose drug in malaria control strategies. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Present address: Joana Pissarra, UMR INTERTRYP, IRD, Montpellier, France. Citation Mendes AM, Albuquerque IS, Machado M, Pissarra J, Meireles P, Prudêncio M. 2017. Inhibition of Plasmodium liver infection by ivermectin. Antimicrob Agents Chemother 61:e02005-16. https://doi.org/10.1128/AAC.02005-16. |
ISSN: | 0066-4804 1098-6596 |
DOI: | 10.1128/aac.02005-16 |